Chronic Heart FailureNCT03615157
Effects of a Home-based Exercise Program on Functional Capacity and Quality of Life in Heart Failure Patients
A study testing Exercise rehabilitation in people with Chronic Heart Failure, run by University of Sao Paulo at 2 sites in Brazil.
Trial summary
Heart failure (HF) is a multisystemic disease leading to exercise intolerance and fatigue. Supervised physical training improves functional capacity, quality of life and reduces hospital admissions in HF patients. Read more about this study
- Who is it for?
- Ages 18 to 75 years
- Conditions the study is for
- Chronic Heart Failure
- What is being tested?
- Exercise rehabilitation
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 30 participants
- Where
- 2 sitesBrazil
- Study dates
- 15 Jan 2018to 15 Feb 2019
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 75 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Chronic heart failure (functional class from NYHA II and III),
- Left ventricle ejection fraction bellow or equal to 40%
- Clinical stability during the last three months
- Medical release for physical training after cardiopulmonary test
Who cannot join
- Uncontrolled arrhythmia
- Pulmonary artery systolic pressure > 35 mmHg by the echo doppler cardiogram,
- Peripheral oxygen saturation < 92% in resting condition
- Respiratory infection in the previous 30 days to the enrollment into the study
- Cognitive, neurological or orthopedic limitations
Trial locations and contacts
2 sites in 1 country.
Brazil2 sites, 2 recruiting
- Recruiting
School of Medicine, University of Sao Paulo
São Paulo, São Paulo, 01246903
NAOMI KONDO NAKAGAWA N KONDO, 11999450626, naomi.kondo@fm.usp.br
Geisa N Andrade, BSc
- Recruiting
Instituto Dante Pazzanese de Cardiologia
São Paulo, 04012-909
Iracema IK Umeda, PhD, +551150856304, iikumeda@usp.br
Geisa N Andrade, +5511993038655, geisandrade@usp.br
About this study
Heart failure (HF) is a multisystemic disease leading to exercise intolerance and fatigue. Supervised physical training improves functional capacity, quality of life and reduces hospital admissions in HF patients. In this way, home physical training may be a good alternative to patients who, for any reason, cannot perform supervised training. Objective: To asses the effects of a home-based training program on functional capacity, sedentary lifestyle and quality of life of patients with chronic HF compared to supervised training.
Read the detailed description
After agreement with the written informed consent, subjects with heart failure (left ventricle ejection fraction bellow or equal 40%) will be included in this study. They will be randomized in two groups: Home-based and Supervised exercise groups. The two groups will be submitted to a twelve-week combined exercise program of aerobic and peripheral muscle training. All volunteers will be assessed at baseline and after twelve weeks of intervention. Peripheric and respiratory muscle strength as well the 6MW analyses were assessed also at 4 and 8 weeks after baseline.
- Conditions
- Chronic Heart Failure
- Being tested
- Exercise rehabilitation
- Keywords
- Home-based exercise, Functional capacity, Chronic Heart Failure
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Exercise rehabilitationOther
Also called Aerobic and resistance training
Patients will be submitted to a twelve-week combined exercise program of aerobic and peripheral muscle training. They will be randomized in two groups: Home-based and Supervised.
| Study group | Role | What they receive |
|---|---|---|
| Home-based exercise rehabilitation | Experimental | Patients will be submitted to a 12-weeks training program, with walking at 60-70% of heart rate reserve monitored by a heart rate monitor (30 minutes/session for 5 days/week) and peripheral muscle training including upper and lower limbs (50% of the 1-maximum repetition test) Receives: Other: Exercise rehabilitation |
| Supervised exercise rehabilitation | Active comparator | Patients will be submitted to a 12-weeks training program, with sessions (3 days/week) supervised by a physiotherapist, including cycling at 60-70% of heart rate reserve and peripheral muscle training of upper and lower limbs (50% of the 1-maximum repetition test) Receives: Other: Exercise rehabilitation |
What is being measured
The primary outcome is the main question the study is designed to answer.
Changes in peak oxygen uptake (ml/kg/min)
Patients will be submitted to cardiopulmonary treadmill exercise tests at baseline and after 12 weeks.
Measured: Baseline and after 12 weeks of exercise programs
Secondary outcomes (13)
Incidence of cardiac events and arrhythmia
By a 24-hours holter system for continuous recording of ambulatory electrocardiographic signs
Measured: Baseline and after 12 weeks of exercise programs
Changes in distance from the six minute walk test (6MW, m)
Patients will be submitted to the 6MW accordingly to the American Thoracic guidelines to assess functional capacity using the six minute walk test
Measured: Baseline and after 4, 8 and 12 weeks of exercise programs
Changes in respiratory muscle strength (cmH2O)
Inspiratory and expiratory muscle strength will be assessed using an analogic pressure transducer
Measured: Baseline and after 4, 8 and 12 weeks of exercise programs
Changes in peripheral muscle strength (N) - Quadriceps mm
Quadriceps strength will be assessed by MicroFet 2 dynamometer (HogganHealth, USA)
Measured: Baseline and after 4, 8 and 12 weeks of exercise program
Changes in peripheral muscle strength (kgf) - Hand grip
Hand grip strength will be assessed by Jamar dynamometer (Sammons Preston Rolyan, 4, Sammons Court, Bolingbrook, IL, 60440)
Measured: Baseline and after 4, 8 and 12 weeks of exercise programs
Changes in daily physical activity and sedentary lifestyle
Patients will use the accelerometer GT3X (Actigraph, Pensacola, FL, USA) on waist during 9 days to asses daily physical activity and sedentary lifestyle
Measured: Baseline and after 12 weeks of exercise programs
Changes in International Physical Activity Questionnaire (IPAQ)
Patients will be classified as sedentary, irregularly active, active or very active according to Matsudo's Classification (2001)
Measured: Baseline and after 12 weeks of exercise programs
Changes in quality of life using SF-36
Quality of life will be assessed by the Short Form-36 Questionnaire
Measured: Baseline and after 12 weeks of exercise programs
Changes in quality of life using MLHF
Quality of life will be assessed by the Minnesota Living with Heart Failure Questionnaire
Measured: Baseline and after 12 weeks of exercise programs
Changes in brain natriuretic peptide (BNP, pg/mL)
A blood sample of 5 ml will be collected in a tube and BNP will be measured
Measured: Baseline and after 12 weeks of exercise programs
Changes in heart rate variability (HRV)
HRV will be analysed from the spectral analysis of R-R intervals obtained from a heart rate monitor (Polar, S810, Kempele, Finland) during the 6MW
Measured: Baseline and after 12 weeks of exercise programs
Changes in sleep quality
Patients will use the accelerometer GT3X (Actigraph, Pensacola, FL, USA) on wrist for nine days to asses Sleep quality. Furthermore, the Pittsburgh Sleep Quality Index will be used to classify patients as good or poor sleepers.
Measured: Baseline and after 12 weeks of exercise programs
Changes in daytime sleepiness
Daytime sleepiness will be assessed by the Epworth Sleepiness Scale
Measured: Baseline and after 12 weeks of exercise programs
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Aug 2018
- Study start15 Jan 2018
- Primary completion15 Dec 2018 (estimated)
- Study completion15 Feb 2019 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Chronic Heart FailureStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- The participants will be randomized in two groups: Home-based and Supervised exercise groups
- Masking
- None (open label)
- Enrolment
- 30 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Sao Paulo
- Sponsor type
- University, hospital or other
- Collaborators
- Instituto Dante Pazzanese de Cardiologia, InCor Heart Institute, Fundação de Amparo à Pesquisa do Estado de São Paulo
- Responsible party
- Principal investigator, NAOMI KONDO NAKAGAWA NAOMI KONDO, University of Sao Paulo
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03615157
- Sponsor's protocol ID
- CEP 411/14
- Status last verified
- Jul 2018
- First submitted
- 30 Jul 2018
- Last updated
- 3 Aug 2018
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: we will insert all individual data in a common website for research
Publications
Andrade GN, Umeda IIK, Fuchs ARCN, Mastrocola LE, Rossi-Neto JM, Moreira DAR, Oliveira PA, Andre CDS, Cahalin LP, Nakagawa NK. Home-based training program in patients with chronic heart failure and reduced ejection fraction: a randomized pilot study. Clinics (Sao Paulo). 2021 Jun 11;76:e2550. doi: 10.6061/clinics/2021/e2550. eCollection 2021.
PubMed 34133657
Study at a glance
From the registry record, last updated by the sponsor on 3 Aug 2018. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effects of a Home-based Exercise Program on Functional Capacity and Quality of Life in Heart Failure Patients
- ClinicalTrials.gov ID
- NCT03615157
- Acronym / sponsor ID
- CEP 411/14
- Conditions
- Chronic Heart Failure
- Keywords
- Home-based exercise, Functional capacity, Chronic Heart Failure
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 30 participants (estimated)
- Lead sponsor
- University of Sao PauloUniversity, hospital or other
- Collaborators
- Instituto Dante Pazzanese de Cardiologia, InCor Heart Institute, Fundação de Amparo à Pesquisa do Estado de São Paulo
- Study start
- 15 Jan 2018 (actual)
- Primary completion
- 15 Dec 2018 (estimated)
- Study completion
- 15 Feb 2019 (estimated)
- First posted
- 3 Aug 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Heart failure (HF) is a multisystemic disease leading to exercise intolerance and fatigue. Supervised physical training improves functional capacity, quality of life and reduces hospital admissions in HF patients. In this way, home physical training may be a good alternative to patients who, for any reason, cannot perform supervised training. Objective: To asses the effects of a home-based training program on functional capacity, sedentary lifestyle and quality of life of patients with chronic HF compared to supervised training.
Detailed description
After agreement with the written informed consent, subjects with heart failure (left ventricle ejection fraction bellow or equal 40%) will be included in this study. They will be randomized in two groups: Home-based and Supervised exercise groups. The two groups will be submitted to a twelve-week combined exercise program of aerobic and peripheral muscle training. All volunteers will be assessed at baseline and after twelve weeks of intervention. Peripheric and respiratory muscle strength as well the 6MW analyses were assessed also at 4 and 8 weeks after baseline.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- The participants will be randomized in two groups: Home-based and Supervised exercise groups
| Arm | Type | Receives |
|---|---|---|
| Home-based exercise rehabilitation | Experimental | Other: Exercise rehabilitationPatients will be submitted to a 12-weeks training program, with walking at 60-70% of heart rate reserve monitored by a heart rate monitor (30 minutes/session for 5 days/week) and peripheral muscle training including upper and lower limbs (50% of the 1-maximum repetition test) |
| Supervised exercise rehabilitation | Active comparator | Other: Exercise rehabilitationPatients will be submitted to a 12-weeks training program, with sessions (3 days/week) supervised by a physiotherapist, including cycling at 60-70% of heart rate reserve and peripheral muscle training of upper and lower limbs (50% of the 1-maximum repetition test) |
Who may qualify
- Ages
- 18 to 75 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Chronic heart failure (functional class from NYHA II and III),
- Left ventricle ejection fraction bellow or equal to 40%
- Clinical stability during the last three months
- Medical release for physical training after cardiopulmonary test
Key exclusion criteria (5 listed)
- Uncontrolled arrhythmia
- Pulmonary artery systolic pressure > 35 mmHg by the echo doppler cardiogram,
- Peripheral oxygen saturation < 92% in resting condition
- Respiratory infection in the previous 30 days to the enrollment into the study
- Cognitive, neurological or orthopedic limitations
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Exercise rehabilitationAlso: Aerobic and resistance trainingPatients will be submitted to a twelve-week combined exercise program of aerobic and peripheral muscle training. They will be randomized in two groups: Home-based and Supervised. | Other | Home-based exercise rehabilitation, Supervised exercise rehabilitation |
Primary outcome
Changes in peak oxygen uptake (ml/kg/min)
Time frame: Baseline and after 12 weeks of exercise programs
Patients will be submitted to cardiopulmonary treadmill exercise tests at baseline and after 12 weeks.
13 secondary outcomes
Incidence of cardiac events and arrhythmia
Time frame: Baseline and after 12 weeks of exercise programs
Changes in distance from the six minute walk test (6MW, m)
Time frame: Baseline and after 4, 8 and 12 weeks of exercise programs
Changes in respiratory muscle strength (cmH2O)
Time frame: Baseline and after 4, 8 and 12 weeks of exercise programs
Changes in peripheral muscle strength (N) - Quadriceps mm
Time frame: Baseline and after 4, 8 and 12 weeks of exercise program
Changes in peripheral muscle strength (kgf) - Hand grip
Time frame: Baseline and after 4, 8 and 12 weeks of exercise programs
Changes in daily physical activity and sedentary lifestyle
Time frame: Baseline and after 12 weeks of exercise programs
Changes in International Physical Activity Questionnaire (IPAQ)
Time frame: Baseline and after 12 weeks of exercise programs
Changes in quality of life using SF-36
Time frame: Baseline and after 12 weeks of exercise programs
Changes in quality of life using MLHF
Time frame: Baseline and after 12 weeks of exercise programs
Changes in brain natriuretic peptide (BNP, pg/mL)
Time frame: Baseline and after 12 weeks of exercise programs
Changes in heart rate variability (HRV)
Time frame: Baseline and after 12 weeks of exercise programs
Changes in sleep quality
Time frame: Baseline and after 12 weeks of exercise programs
Changes in daytime sleepiness
Time frame: Baseline and after 12 weeks of exercise programs
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Aug 2018.
- Derived from this study: PubMed 34133657Andrade GN, Umeda IIK, Fuchs ARCN, Mastrocola LE, Rossi-Neto JM, Moreira DAR, Oliveira PA, Andre CDS, Cahalin LP, Nakagawa NK. Home-based training program in patients with chronic heart failure and reduced ejection fraction: a randomized pilot study. Clinics (Sao Paulo). 2021 Jun 11;76:e2550. doi: 10.6061/clinics/2021/e2550. eCollection 2021.
- Individual participant dataSharing planned: Yes. we will insert all individual data in a common website for research
Related trials for Chronic Heart Failure
Active, not recruiting
Heart Failure Patient Management and Interventions Using Continuous Patient Monitoring Outside Hospitals and Real-world Data
Chronic Heart Failure, Heart Transplant Recipient
Recruiting
Vasopressor Agents in Pulmonary Hypertension Crisis
Pulmonary Arterial Hypertension (PAH), Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
RecruitingObservational study
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Rare Disorders, Undiagnosed Disorders
RecruitingPhase 4
Empagliflozin in Heart Failure With Reduced Ejection Fraction and End Stage Renal Disease
Heart Failure With Reduced Ejection Fraction, End Stage Renal Disease on Dialysis
Not yet recruitingPhase 3
Efficacy of Lipoic Acid on Chronic Ischemic Heart Failure Patients
Heart Failure Due to Coronary Artery Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Exercise rehabilitation in people with Chronic Heart Failure, run by University of Sao Paulo at 2 sites in Brazil.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 3 Aug 2018. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Naomi K Nakagawa, PhD (+551130618529, naomi.kondo@fm.usp.br), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Changes in peak oxygen uptake (ml/kg/min) (time frame: Baseline and after 12 weeks of exercise programs). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03615157, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Aug 2018.